Prescient Therapeutics launches share purchase plan to raise $8 million
Clinical-stage oncology company developing personalised therapies Prescient Therapeutics (ASX:PTX) has announced a Share Purchase Plan...
Clinical-stage oncology company developing personalised therapies Prescient Therapeutics (ASX:PTX) has announced a Share Purchase Plan...
(ASX:PTX) is presenting new preclinical data on OmniCAR at the Cell and Gene Meeting in...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.